I.CERAM |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1 EUR | -4.76% |
|
-7.41% | -65.52% |
| Feb. 07 | I.Ceram: successful animal health implant | CF |
| Jan. 17 | I.Ceraam: up to 1.4 million in new financing | CF |
Valuation
| Fiscal Period: December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 37.64 | 17.41 | 11.82 | 8.825 | 4.791 | 2.988 |
| Enterprise Value (EV) 1 | 36.96 | 17.08 | 12.96 | 10.17 | 6.938 | 4.789 |
| P/E ratio | -17.7 x | -6.58 x | -4.3 x | -5.81 x | -6.31 x | -3.18 x |
| Yield | - | - | - | - | - | - |
| Capitalization / Revenue | 25.5 x | 11.7 x | 7.28 x | 5.79 x | 3.07 x | 2.09 x |
| EV / Revenue | 25 x | 11.5 x | 7.98 x | 6.67 x | 4.44 x | 3.35 x |
| EV / EBITDA | -25.3 x | -8.21 x | -6.57 x | -10.3 x | -46 x | -23.8 x |
| EV / FCF | -25.7 x | -9.29 x | -146 x | 17.6 x | -8.74 x | - |
| FCF Yield | -3.89% | -10.8% | -0.69% | 5.67% | -11.4% | - |
| Price to Book | 5.77 x | 2.51 x | 2.86 x | 3.38 x | 2.59 x | 1.47 x |
| Nbr of stocks (in thousands) | 266 | 294 | 293 | 292 | 292 | 293 |
| Reference price 2 | 141.4 | 59.20 | 40.40 | 30.20 | 16.40 | 10.20 |
| Announcement Date | 4/27/18 | 4/24/19 | 4/30/20 | 4/30/21 | 4/28/22 | 5/6/23 |
1EUR in Million2EUR
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|
| Net sales 1 | 1.479 | 1.489 | 1.624 | 1.525 | 1.561 | 1.43 |
| EBITDA 1 | -1.462 | -2.081 | -1.972 | -0.9883 | -0.1509 | -0.2009 |
| EBIT 1 | -2.059 | -2.708 | -2.657 | -1.663 | -0.7989 | -0.8489 |
| Operating Margin | -139.23% | -181.81% | -163.62% | -109.07% | -51.16% | -59.35% |
| Earnings before Tax (EBT) 1 | -2.063 | -2.739 | -2.784 | -1.58 | -0.8122 | -1.227 |
| Net income 1 | -2.158 | -2.632 | -2.765 | -1.528 | -0.7722 | -0.9365 |
| Net margin | -145.9% | -176.72% | -170.28% | -100.2% | -49.46% | -65.48% |
| EPS 2 | -8.000 | -9.000 | -9.400 | -5.200 | -2.600 | -3.212 |
| Free Cash Flow 1 | -1.436 | -1.838 | -0.0889 | 0.5773 | -0.7935 | - |
| FCF margin | -97.12% | -123.42% | -5.47% | 37.87% | -50.82% | - |
| FCF Conversion (EBITDA) | - | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - |
| Announcement Date | 4/27/18 | 4/24/19 | 4/30/20 | 4/30/21 | 4/28/22 | 5/6/23 |
1EUR in Million2EUR
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|
| Net Debt 1 | - | - | 1.14 | 1.35 | 2.15 | 1.8 |
| Net Cash position 1 | 0.68 | 0.33 | - | - | - | - |
| Leverage (Debt/EBITDA) | - | - | -0.5781 x | -1.364 x | -14.24 x | -8.965 x |
| Free Cash Flow 1 | -1.44 | -1.84 | -0.09 | 0.58 | -0.79 | - |
| ROE (net income / shareholders' equity) | -28.2% | -39.1% | -49.9% | -45.3% | -34.6% | -48.4% |
| ROA (Net income/ Total Assets) | -12.4% | -17.7% | -20.6% | -16.9% | -8.97% | -10.2% |
| Assets 1 | 17.44 | 14.89 | 13.45 | 9.047 | 8.606 | 9.216 |
| Book Value Per Share 2 | 24.50 | 23.60 | 14.10 | 8.930 | 6.340 | 6.930 |
| Cash Flow per Share 2 | 9.060 | 6.060 | 0.4300 | 0.4900 | 0.4800 | 0.0400 |
| Capex 1 | 0.96 | 0.79 | 0.58 | 0.14 | 0.21 | - |
| Capex / Sales | 65.05% | 53.31% | 35.91% | 8.99% | 13.39% | - |
| Announcement Date | 4/27/18 | 4/24/19 | 4/30/20 | 4/30/21 | 4/28/22 | 5/6/23 |
1EUR in Million2EUR
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -65.52% | 311K | |
| +12.07% | 128B | |
| -9.04% | 10.65B | |
| +0.91% | 8.82B | |
| +16.72% | 7.19B | |
| +25.15% | 4.99B | |
| +7.17% | 3.4B | |
| -1.36% | 3.03B | |
| -8.73% | 2.14B | |
| -10.15% | 2B |
- Stock Market
- Equities
- ALICR Stock
- Financials I.Ceram
